ImmunoPrecise to present at The Benchmark Company’s Discovery One-on-One Virtual Video Investor Conference on Thursday December 2, 2021
VICTORIA, BC – IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (NASDAQ: IPA) (TSX VENTURE: IPA) is presenting at the Benchmark Company’s Discovery One-on-One Virtual Video Investor Conference. The conference is… Read More




